Literature DB >> 16389539

Probiotics to prevent urinary tract infections: the rationale and evidence.

Gregor Reid1, Andrew W Bruce.   

Abstract

For over 30 years, urologists have recognized in females, that urinary pathogens almost always infect the host through ascension from the rectum, vagina to the urethra and bladder. Likewise, the Lactobacillus organisms that predominate in the vagina of healthy women, spread from the rectum and perineum and form a barrier in the vagina to bladder entry by uropathogens. The concept of artificially boosting the lactobacilli numbers through probiotic instillation has long been conceived, but only in recent years shown to be possible. Not all lactobacilli are effective, and to date clinical efficacy only exists for Lactobacillus rhamnosus GR-1 and Lactobacillus reuteri B-54 and RC-14. These strains are only commercially available in Austria, and therefore for most urologists, while some probiotic organisms may reduce the recurrences of bladder cancer or oxaluria, no probiotics can be recommended widely to prevent UTI at present.

Entities:  

Mesh:

Year:  2005        PMID: 16389539     DOI: 10.1007/s00345-005-0043-1

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  47 in total

1.  Lactobacillus strains and vaginal ecology.

Authors:  Peter Cadieux; Jeremy Burton; Gillian Gardiner; Ivo Braunstein; Andrew W Bruce; C Yong Kang; Gregor Reid
Journal:  JAMA       Date:  2002-04-17       Impact factor: 56.272

2.  Vaccine Development for the Prevention of Urinary Tract Infections.

Authors:  Walter J. Hopkins; David T. Uehling
Journal:  Curr Infect Dis Rep       Date:  2002-12       Impact factor: 3.725

3.  Utilization of the intestinal tract as a delivery system for urogenital probiotics.

Authors:  L Morelli; D Zonenenschain; M Del Piano; P Cognein
Journal:  J Clin Gastroenterol       Date:  2004-07       Impact factor: 3.062

4.  Influence of three-day antimicrobial therapy and lactobacillus vaginal suppositories on recurrence of urinary tract infections.

Authors:  G Reid; A W Bruce; M Taylor
Journal:  Clin Ther       Date:  1992 Jan-Feb       Impact factor: 3.393

5.  Distribution of the serine protease autotransporters of the Enterobacteriaceae among extraintestinal clinical isolates of Escherichia coli.

Authors:  Nick J Parham; Samantha J Pollard; Mickaël Desvaux; Anthony Scott-Tucker; Chengjie Liu; Amanda Fivian; Ian R Henderson
Journal:  J Clin Microbiol       Date:  2005-08       Impact factor: 5.948

6.  Preventive and therapeutic administration of an indigenous Lactobacillus sp. strain against Proteus mirabilis ascending urinary tract infection in a mouse model.

Authors:  Martín Fraga; Paola Scavone; Pablo Zunino
Journal:  Antonie Van Leeuwenhoek       Date:  2005-07       Impact factor: 2.271

7.  Assessment of the capacity of Lactobacillus to inhibit the growth of uropathogens and block their adhesion to vaginal epithelial cells.

Authors:  J Osset; R M Bartolomé; E García; A Andreu
Journal:  J Infect Dis       Date:  2000-12-29       Impact factor: 5.226

Review 8.  Escherichia coli mediated urinary tract infections: are there distinct uropathogenic E. coli (UPEC) pathotypes?

Authors:  Carl F Marrs; Lixin Zhang; Betsy Foxman
Journal:  FEMS Microbiol Lett       Date:  2005-09-06       Impact factor: 2.742

9.  Combination of vaginal pH with vaginal sialidase and prolidase activities for prediction of low birth weight and preterm birth.

Authors:  Sabina Cauci; James McGregor; Poul Thorsen; Jakob Grove; Secondo Guaschino
Journal:  Am J Obstet Gynecol       Date:  2005-02       Impact factor: 8.661

10.  Recurrent urethritis in women.

Authors:  A W Bruce; P Chadwick; A Hassan; G F VanCott
Journal:  Can Med Assoc J       Date:  1973-04-21       Impact factor: 8.262

View more
  34 in total

1.  Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation.

Authors:  Les Dethlefsen; David A Relman
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-16       Impact factor: 11.205

Review 2.  The human urinary microbiome and how it relates to urogynecology.

Authors:  Jenifer Schneeweiss; Marianne Koch; Wolfgang Umek
Journal:  Int Urogynecol J       Date:  2016-01-25       Impact factor: 2.894

Review 3.  Proposed model: mechanisms of immunomodulation induced by probiotic bacteria.

Authors:  C Maldonado Galdeano; A de Moreno de LeBlanc; G Vinderola; M E Bibas Bonet; G Perdigón
Journal:  Clin Vaccine Immunol       Date:  2007-03-14

4.  Probiotics prophylaxis in children with persistent primary vesicoureteral reflux.

Authors:  Seung Joo Lee; Yoon Hee Shim; Su Jin Cho; Jung Won Lee
Journal:  Pediatr Nephrol       Date:  2007-05-26       Impact factor: 3.714

5.  Nutraceuticals in Prostate Disease: The Urologist's Role.

Authors:  J Curtis Nickel; Daniel Shoskes; Claus G Roehrborn; Mark Moyad
Journal:  Rev Urol       Date:  2008

6.  Lactobacillus colonization status in infants with urinary tract infection.

Authors:  Jung Won Lee; Yoon Hee Shim; Seung Joo Lee
Journal:  Pediatr Nephrol       Date:  2008-09-10       Impact factor: 3.714

7.  Evaluation of Lactic Acid Bacteria Isolated from Fermented Plant Products for Antagonistic Activity Against Urinary Tract Pathogen Staphylococcus saprophyticus.

Authors:  Cheng-Chih Tsai; Tzu-Min Lai; Pei-Pei Lin; You-Miin Hsieh
Journal:  Probiotics Antimicrob Proteins       Date:  2018-06       Impact factor: 4.609

Review 8.  Antimicrobial mechanisms of the urinary tract.

Authors:  Milan Chromek; Annelie Brauner
Journal:  J Mol Med (Berl)       Date:  2007-09-06       Impact factor: 4.599

9.  The current evidence based medical management of vesicoureteral reflux: The Sickkids protocol.

Authors:  Sumit Dave; Antoine E Khoury
Journal:  Indian J Urol       Date:  2007-10

10.  Vaginal microbiota and the use of probiotics.

Authors:  Sarah Cribby; Michelle Taylor; Gregor Reid
Journal:  Interdiscip Perspect Infect Dis       Date:  2009-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.